English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 8 November 2019, 18:00 HKT/SGT
Share:
    

Source: Holista CollTech Ltd
iGalen and Holista announce resolution with ATM Metabolics

PERTH, AU, Nov 8, 2019 - (ACN Newswire) - Holista, a research-driven biotech company that develops natural ingredient and wellness products, and its distributor iGalen are pleased to announce that they have resolved their disputes with ATM Metabolics and its founder Dr. Joseph Ahrens, a two time Nobel prize nominee and discoverer of Emulin. As a result, they will no longer be carrying Emulin.

If you would like to purchase the product in the future, please contact ATM at www.atmmetabolics.com. We wish ATM and Dr. Ahrens success in their future endeavours, and thank them for working with us to resolve the disputes.

Holista CollTech (ASX:HCT) is a research-driven biotech company. Headquartered in Perth with operations in Malaysia, it is dedicated to delivering first-class natural ingredients and wellness products globally. Holista's ingredients include low-GI baked products, reduced-sodium salts, low-fat fried foods and low calorie sugar. www.holistaco.com.

iGalen markets a range of premium-quality nutritional supplements that are sold directly to Distributors and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Singapore, Mexico, Malaysia, and the Philippines. Visit www.igalen.com.

Topic: Legal Action
Sectors: BioTech, HealthCare
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Holista CollTech Ltd Releated News
Oct 18, 2019 14:45 HKT/SGT
Malaysian Companies Develop Ingredients for World's First Healthy Bubble Tea
Oct 17, 2019 17:00 HKT/SGT
Holista Collaborates to Develop World's First Combined Suite of Healthybubble Tea Ingredients amidst Concerns of Diabetes and Obesity
Oct 17, 2019 17:00 HKT/SGT
HOLISTA响应全球对糖尿病和肥胖症的担忧 携手合作伙伴开发全球首款健康泡泡茶配料组合
Oct 17, 2019 17:00 HKT/SGT
HOLISTA響應全球對糖尿病和肥胖症的擔憂 攜手合作夥伴開發全球首款健康泡泡茶配料組合
July 24, 2019 15:00 HKT/SGT
Global BioLife unveils naturally modified Laetose at Harvard Global Catalyst Health Summit
More news >>
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575